Björn Over

2.0k total citations · 1 hit paper
9 papers, 1.5k citations indexed

About

Björn Over is a scholar working on Computational Theory and Mathematics, Molecular Biology and Pharmacology. According to data from OpenAlex, Björn Over has authored 9 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Computational Theory and Mathematics, 7 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Björn Over's work include Computational Drug Discovery Methods (8 papers), Chemical Synthesis and Analysis (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Björn Over is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Chemical Synthesis and Analysis (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Björn Over collaborates with scholars based in Sweden, Germany and Australia. Björn Over's co-authors include Jan Kihlberg, B.C. Doak, Fabrizio Giordanetto, Pär Matsson, Herbert Waldmann, Daniel Rauh, Stefan Wetzel, Christian Grütter, Yasushi Nakai and Steffen Renner and has published in prestigious journals such as Advanced Drug Delivery Reviews, Nature Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Björn Over

9 papers receiving 1.4k citations

Hit Papers

Oral Druggable Space beyond the Rule of 5: Insights from ... 2014 2026 2018 2022 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Björn Over Sweden 9 974 459 447 216 195 9 1.5k
B.C. Doak Australia 15 1.2k 1.2× 524 1.1× 456 1.0× 151 0.7× 242 1.2× 32 1.8k
Brian Y. Feng United States 11 1.2k 1.2× 599 1.3× 322 0.7× 212 1.0× 138 0.7× 18 1.9k
Raman Sharma United States 27 785 0.8× 284 0.6× 413 0.9× 229 1.1× 208 1.1× 74 2.0k
Vasanthanathan Poongavanam Sweden 29 1.5k 1.6× 774 1.7× 618 1.4× 172 0.8× 413 2.1× 76 2.5k
Emanuele Carosati Italy 25 1.1k 1.1× 542 1.2× 656 1.5× 177 0.8× 232 1.2× 47 2.0k
Cameron R. Pye United States 13 995 1.0× 206 0.4× 350 0.8× 312 1.4× 112 0.6× 20 1.3k
Ruth Brenk United Kingdom 27 1.5k 1.5× 659 1.4× 754 1.7× 195 0.9× 120 0.6× 61 2.3k
Siegfried S. F. Leung United States 14 921 0.9× 188 0.4× 513 1.1× 119 0.6× 142 0.7× 14 1.4k
David Lagorce France 25 1.4k 1.4× 933 2.0× 361 0.8× 287 1.3× 193 1.0× 34 2.6k
Luca Laraia Denmark 23 1.0k 1.0× 219 0.5× 798 1.8× 428 2.0× 134 0.7× 52 1.9k

Countries citing papers authored by Björn Over

Since Specialization
Citations

This map shows the geographic impact of Björn Over's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Over with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Over more than expected).

Fields of papers citing papers by Björn Over

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Over. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Over. The network helps show where Björn Over may publish in the future.

Co-authorship network of co-authors of Björn Over

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Over. A scholar is included among the top collaborators of Björn Over based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Over. Björn Over is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Poongavanam, Vasanthanathan, Björn Over, Stefan Geschwindner, et al.. (2020). Mining Natural Products for Macrocycles to Drug Difficult Targets. Journal of Medicinal Chemistry. 64(2). 1054–1072. 33 indexed citations
2.
Sebastiano, Matteo Rossi, B.C. Doak, Maria Backlund, et al.. (2018). Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5. Journal of Medicinal Chemistry. 61(9). 4189–4202. 157 indexed citations
3.
Matsson, Pär, B.C. Doak, Björn Over, & Jan Kihlberg. (2016). Cell permeability beyond the rule of 5. Advanced Drug Delivery Reviews. 101. 42–61. 220 indexed citations
4.
Over, Björn, Pär Matsson, Christian Tyrchan, et al.. (2016). Structural and conformational determinants of macrocycle cell permeability. Nature Chemical Biology. 12(12). 1065–1074. 160 indexed citations
5.
Doak, B.C., Björn Over, Fabrizio Giordanetto, & Jan Kihlberg. (2014). Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates. Chemistry & Biology. 21(9). 1115–1142. 555 indexed citations breakdown →
6.
Over, Björn, Patrick McCarren, Per Artursson, et al.. (2014). Impact of Stereospecific Intramolecular Hydrogen Bonding on Cell Permeability and Physicochemical Properties. Journal of Medicinal Chemistry. 57(6). 2746–2754. 73 indexed citations
7.
Over, Björn, Stefan Wetzel, Christian Grütter, et al.. (2012). Natural-product-derived fragments for fragment-based ligand discovery. Nature Chemistry. 5(1). 21–28. 233 indexed citations
9.
Steuber, H., Björn Over, Hans‐Dieter Gerber, et al.. (2010). Fragment‐Based Lead Discovery: Screening and Optimizing Fragments for Thermolysin Inhibition. ChemMedChem. 5(6). 930–940. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026